Treatment satisfaction in patients with type 2 diabetes is significantly improved with liraglutide, the once-daily GLP-1 analogue versus sitagliptin, both combined with metformin

被引：0
|
作者：
Montanya Mias, E. [1 ]
Cuddihy, R. [2 ]
Pratley, R. [3 ]
Hammer, M. [4 ]
Thomsen, A. [4 ]
Davies, M. J. [5 ]
机构：
[1] IDIBELL Hosp Univ Bellvitge, Barcelona, Spain
[2] Int Diabet Ctr, Minneapolis, MN USA
[3] Univ Vermont, Burlington, VT 05405 USA
[4] Novo Nordisk AS, Soborg, Denmark
[5] Univ Leicester, Leicester LE1 7RH, Leics, England
来源：
DIABETOLOGIA | 2010年 / 53卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
832
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Liraglutide: a once-daily GLP-1 analogue for the treatment of Type 2 diabetes mellitus
    Vilsboll, Tina
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2007, 16 (02) : 231 - 237
  • [2] Liraglutide: once-daily GLP-1 agonist for the treatment of type 2 diabetes
    Ryan, Gina J.
    Hardy, Yolanda
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2011, 36 (03) : 260 - 274
  • [3] Effects of the once-daily human GLP-1 analogue liraglutide on appetite and energy intake in type 2 diabetes
    Horowitz, M.
    Flint, A.
    Doran, S.
    Rasmussen, M. F.
    Kapitza, C.
    Andreasen, A. H.
    Jones, K. L.
    Zdravkovic, M.
    Chapman, I. M.
    DIABETOLOGIA, 2008, 51 : S355 - S355
  • [4] Liraglutide, a once-daily human GLP-1 analog, significantly improves β-cell function in subjects with type 2 diabetes
    Matthews, David
    Marre, Michel
    Le-Thl, T. U. Duyen
    Zdravkovic, Milan
    Simo, Rafael
    DIABETES, 2008, 57 : A150 - A151
  • [5] Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes
    Seino, Y.
    Rasmussen, M. F.
    Nishida, T.
    Kaku, K.
    CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (05) : 1013 - 1022
  • [6] The effect of the once-daily human GLP-1 analogue liraglutide on the pharmacokinetics of paracetamol
    Kapitza, Christoph
    Flint, Anne
    Hindsberger, Charlotte
    Zdravkovic, Milan
    DIABETES, 2008, 57 : A593 - A593
  • [7] Significantly better glycaemic control and weight reduction with liraglutide, a once-daily human GLP-1 analogue, compared with glimepiride: all as monotherapy in type 2 diabetes
    Garber, A.
    Henry, R.
    Ratner, R.
    Garcia-Hernandez, P.
    Pattzi, H. M. Rodriguez
    Olvera-Alvarez, I.
    Hale, P. M.
    Zdravkovic, M.
    Bode, B.
    DIABETOLOGIA, 2008, 51 : S358 - S359
  • [8] The once-daily human GLP-1 analogue liraglutide impacts appetite and energy intake in patients with type 2 diabetes after short-term treatment
    Flint, A.
    Kapitza, C.
    Zdravkovic, M.
    DIABETES OBESITY & METABOLISM, 2013, 15 (10): : 958 - 962
  • [9] Molecular, pharmacological and clinical aspects of liraglutide, a once-daily human GLP-1 analogue
    Russell-Jones, David
    MOLECULAR AND CELLULAR ENDOCRINOLOGY, 2009, 297 (1-2) : 137 - 140
  • [10] Patient-reported rating of gastrointestinal adverse effects during treatment of type 2 diabetes with the once-daily human GLP-1 analogue, liraglutide
    Horowitz, M.
    Vilsboll, T.
    Zdravkovic, M.
    Hammer, M.
    Madsbad, S.
    DIABETES OBESITY & METABOLISM, 2008, 10 (07): : 593 - U4
12345